Abstract
Here we present a 45-year-old male patient who suffered from psoriatic arthritis (PsA), for which adalimumab (80 mg every other week) was effective. Dose escalation of a TNF-α antagonist should be considered for patients showing an inadequate response for disease stabilization in PsA.
Author supplied keywords
Cite
CITATION STYLE
APA
Nanke, Y., Kobashigawa, T., Sugimoto, N., Yamanaka, H., & Kotake, S. (2019). A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week). Immunological Medicine, 42(2), 99–102. https://doi.org/10.1080/25785826.2019.1657255
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free